Autoimmune inner ear disease (AIED) represents a rare yet potentially reversible cause of sensorineural hearing loss, characterized by immune-mediated damage to cochlear and vestibular structures. Unlike autoimmunity, which is driven by adaptive immune responses and autoantibodies, autoinflammation stems from innate immune system dysregulation, typically involving inflammasome hyperactivation....
No immediate practice change; this is a review of emerging biomarkers not yet validated for routine clinical use, but audiologists should be aware of advancing diagnostics for autoimmune/autoinflammatory sensorineural hearing loss to facilitate timely specialist referral.
Accurate early diagnosis of immune-mediated hearing loss—currently hampered by a lack of validated biomarkers—could shift management away from empirical steroids toward precision immunotherapy, potentially preserving hearing in a rare but reversible patient group.
- 01Review in Mol Biol Rep covering biomarkers for autoimmune and autoinflammatory inner ear disorders.
- 02Both conditions can cause sensorineural hearing loss (nerve-related hearing loss) but require different treatments.
- 03No single validated biomarker currently exists for routine differential diagnosis of these disorders.
- 04Emerging candidates include immune cell panels, cytokines, and genetic/proteomic markers.
- 05Earlier accurate diagnosis could reduce inappropriate empirical steroid use and improve hearing preservation outcomes.
Autoimmune and autoinflammatory inner ear disorders are a cause of potentially reversible sensorineural hearing loss.
guidelinesupportedCurrently available biomarkers are insufficient for reliable differential diagnosis of autoimmune versus autoinflammatory inner ear disease.
studypartially supportedAdvances in biomarker research could enable more targeted and effective treatment of immune-mediated inner ear disorders.
opinionunclear- PMID
- 42340468
- DOI
- 10.1007/s11033-026-12201-2.
- Journal
- Molecular Biology Reports
- Publication type
- review
- Evidence level
- 5
- Population
- Patients with autoimmune or autoinflammatory inner ear disorders causing sensorineural hearing loss
- Intervention
- Biomarker-based differential diagnostic approaches
Primary outcomes
Diagnostic accuracy of candidate biomarkers for differentiating autoimmune from autoinflammatory inner ear disease; Potential to guide targeted treatment selection